Skip to main content
. 2011 Sep 7;3(2):e11. doi: 10.4081/idr.2011.e11

Table 1. Clinical summary of hysterectomy donors.

Subject ID# Age Diagnosis resulting in hysterectomy Menstrual cycle stage/Hormone therapy
For CCR5 and CD4 transcription
 5041 39 Fibroids Secretory/none
 5063 55 Uterine bleeding Unknown/none
 5082 40 Prolapse Secretory/none
 5165 52 Menorraghia Unknown/none
 5177 55 Fibroids Atrophic/none
 5210 62 Prolapse Atrophic/estrace cream*
 5995 48 Pelvic Pain Unknown/none
For HIV-1 Reverse transcription
 5207 49 Prolapse Secretory/none
 5210 62 Prolapse Atrophic/estrace cream
 5233 44 Fibroids Inactive/Lupron depot*
 5254 52 Fibroids Unknown/none
For IFN-transcription
 5805 67 Prolapse Atrophic/none
 5823 47 Fibroids Unknown/alesse-28*
 5879 59 Prolapse Unknown/none
*

Estrace cream is a synthetic form of topically applied estrogen commonly used to treat vaginal atrophy; Lupron depot is a gonadotropin-releasing hormone sometimes used before hysterectomy in women with menorrhagia and anemia to prevent further bleeding prior to surgery; Alesse-28 is a synthetic progesterone and estradiol combination used as a contraceptive.